Parenteral MCT/ω‐3 Polyunsaturated Fatty Acid–Enriched Intravenous Fat Emulsion Is Associated With Cytokine and Fatty Acid Profiles Consistent With Attenuated Inflammatory Response in Preterm Neonates
- 16 September 2015
- journal article
- research article
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 31 (2), 235-244
- https://doi.org/10.1177/0884533615602011
Abstract
Background: Soybean oil–based intravenous fat emulsion (IVFE) administered to preterm neonates can induce oxidative stress and inflammatory response, which are associated with severe complications of prematurity. This study aimed to test the hypothesis that administration of medium‐chain triglyceride (MCT)/ω‐3 polyunsaturated fatty acid (PUFA)–enriched IVFE in preterm neonates is associated with a cytokine and fatty acid (FA) profile consistent with attenuated inflammatory response. Patients/Methods: In a double‐blind randomized study, 60 preterm neonates (gestational age 26–32 weeks) were randomized to receive either MCT/ω‐3 PUFA‐enriched IVFE (intervention group) or soybean oil–based IVFE (control group). Serum biochemistry, tumor necrosis factor (TNF)–α, interleukin (IL)–6, IL‐8, α‐tocopherol, and FAs were assessed at baseline, on day of life 15, and day of life 30 or at the end of intervention. Results: All cytokine levels changed significantly across the 3 time points, whereas the type of IVFE had a significant effect on final IL‐6 and IL‐8 levels, which were lower in the intervention group. The difference in final IL‐6 and IL‐8 levels remained significant after controlling for bronchopulmonary dysplasia and/or infection. α‐Tocopherol and FA values changed significantly over time. MCT/ω‐3 PUFA‐enriched IVFE administration was associated with significantly higher α‐tocopherol, eicosapentaenoic acid, docosahexaenoic acid, and ω‐3 PUFAs and lower linolenic acid, total PUFA, and ω‐6/ω‐3 PUFA values compared with soybean oil–based IVFE. Both IVFEs were well tolerated. Conclusion: Compared with the soybean oil–based IVFE, the MCT/ω‐3 PUFA‐enriched IVFE is associated with a more favorable cytokine and FA profile consistent with attenuated inflammatory response in preterm neonates.Keywords
This publication has 59 references indexed in Scilit:
- Short‐Term Use of Parenteral Nutrition With a Lipid Emulsion Containing a Mixture of Soybean Oil, Olive Oil, Medium‐Chain Triglycerides, and Fish OilJournal of Parenteral and Enteral Nutrition, 2012
- Targeting Inflammation to Prevent Bronchopulmonary Dysplasia: Can New Insights Be Translated Into Therapies?PEDIATRICS, 2011
- Effects of parenteral soybean oil lipid emulsion on the long‐chain polyunsaturated fatty acid profile in very‐low‐birth‐weight infantsActa Paediatrica, 2011
- Effects of the ω‐6:ω‐3 Fatty Acid Ratio of Fat Emulsions on the Fatty Acid Composition in Cell Membranes and the Anti‐Inflammatory ActionJournal of Parenteral and Enteral Nutrition, 2010
- Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directionsIntensive Care Medicine, 2010
- Parenteral Lipid Emulsions Based on Olive Oil Compared With Soybean Oil in Preterm (<28 Weeks' Gestation) Neonates: A Randomised Controlled TrialJournal of Pediatric Gastroenterology and Nutrition, 2009
- Parenteral Fish Oil Improves Outcomes in Patients With Parenteral Nutrition-Associated Liver InjuryAnnals of Surgery, 2009
- The role of fatty acids and caveolin-1 in tumor necrosis factor α–induced endothelial cell activationMetabolism, 2008
- Respiratory distress syndrome-associated inflammation is related to early but not late peri/intraventricular hemorrhage in preterm infantsThe Journal of Pediatrics, 2006
- Safe and efficacious prolonged use of an olive oil-based lipid emulsion (ClinOleic©) in chronic intestinal failureClinical Nutrition, 2004